Apparently MBP8298, now called Dirucotide, is being scraped. I volunteered for this clinical trial and was turned down. I was hoping it would be another MS treatment. All trials on this will be scapped for now.

http://www.reuters.com/article/rbssP...54890120090727

BioMS Medical Corp Investor Relations said:

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial
In Secondary Progressive Multiple Sclerosis.

INDIANAPOLIS, Indiana and EDMONTON, Alberta, July 27, 2009 – Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp. (TSX: MS) today announced that dirucotide did not meet the primary endpoint of delaying disease progression, as measured by the Expanded Disability Status Scale (EDSS), during the two-year MAESTRO-01 Phase III trial in patients with secondary progressive multiple sclerosis (SPMS).

In addition, there were no statistically significant differences between dirucotide and placebo on the secondary endpoints of the study.